Table 5.
The expression correlation of immunologic indicators in tumors positive for single subtype marker of primary small cell lung cancer.
| Variable | ASCL1 | NEUROD1 | POU2F3 | YAP1 | ||||
|---|---|---|---|---|---|---|---|---|
| r | P | r | P | r | P | r | P | |
| CD8 | -0.229 | 0.011 | 0.074 | 0.424 | 0.045 | 0.619 | -0.101 | 0.271 |
| FoxP3 | 0.380 | 0.000 | 0.171 | 0.067 | 0.130 | 0.161 | 0.077 | 0.413 |
| PD1 | -0.255 | 0.005 | -0.085 | 0.358 | -0.104 | 0.257 | -0.160 | 0.086 |
| PDL1 | -0.062 | 0.514 | -0.200 | 0.035 | 0.080 | 0.401 | -0.068 | 0.478 |
| CTLA4 | 0.260 | 0.005 | 0.093 | 0.329 | 0.302 | 0.001 | -0.200 | 0.036 |
| E-Cadherin | 0.093 | 0.306 | -0.131 | 0.152 | 0.172 | 0.056 | 0.053 | 0.565 |
| N-Cadherin | 0.127 | 0.160 | 0.071 | 0.439 | 0.068 | 0.450 | 0.137 | 0.134 |
| TGFβ1 | 0.237 | 0.011 | 0.208 | 0.028 | 0.056 | 0.511 | 0.174 | 0.058 |
ASCL1, achaete-scute homologue 1; NEUROD1, neurogenic differentiation factor 1; POU2F3, POU class 2 homeobox 3; YAP1, yes-associated protein 1; FoxP3, forkhead box P3; PD1, programmed cell death 1; PDL1, programmed cell death ligand 1; CTLA4, cytotoxic T lymphocyte antigen 4; TGFβ1, transforming growth factor beta 1.